Cidara Therapeutics's change in inventory for the quarter that ended in Mar. 2024 was $-1.17 Mil. It means Cidara Therapeutics's inventory
increased by $1.17 Mil
from Dec. 2023 to Mar. 2024 .
Cidara Therapeutics's change in inventory for the fiscal year that ended in Dec. 2023 was $-6.10 Mil. It means Cidara Therapeutics's inventory
increased by $6.10 Mil
from Dec. 2022 to Dec. 2023 .
Days Inventory indicates the number of days of goods in sales that a company has in the inventory.
Cidara Therapeutics's Days Inventory for the quarter that ended in Mar. 2024 was 390.16.
Inventory Turnover measures how fast the company turns over its inventory within a year.
Cidara Therapeutics's Inventory Turnover for the quarter that ended in Mar. 2024 was 0.23.
Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
Cidara Therapeutics's Inventory-to-Revenue for the quarter that ended in Mar. 2024 was 0.79.
Cidara Therapeutics Change In Inventory Historical Data
The historical data trend for Cidara Therapeutics's Change In Inventory can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Cidara Therapeutics Change In Inventory Calculation
Change In Inventory is the difference between last period's ending inventory and the current period's ending inventory.
Change In Inventory for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $-7.27 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Cidara Therapeutics (NAS:CDTX) Change In Inventory Explanation
1. Days Inventory indicates the number of days of goods in sales that a company has in the inventory.
Cidara Therapeutics's Days Inventory for the quarter that ended in is calculated as:
3. Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
Cidara Therapeutics's Inventory to Revenue for the quarter that ended in Mar. 2024 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Cidara Therapeutics Change In Inventory Related Terms
Thank you for viewing the detailed overview of Cidara Therapeutics's Change In Inventory provided by GuruFocus.com. Please click on the following links to see related term pages.
Cidara Therapeutics (Cidara Therapeutics) Business Description
Cidara Therapeutics Inc is a biotechnology company. It is focused on the discovery, development, and commercialization of novel anti-infectives for the treatment and prevention of diseases. The company's Rezafungin is a novel molecule in the echinocandin class of antifungals. It is developing rezafungin for the first-line treatment and prevention of serious, invasive fungal infections which are associated with high mortality rates. Its other product candidates include CD377, CD388, RSV AVC, HIV AVC, and SARS-CoV-2 AVC.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
CDTX has been successfully added to your 